AVTX
Avalo Therapeutics Inc.
$16.72
-$1.31(-7.27%)
52
Overall
60
Value
66
Tech
31
Quality
Market Cap
$155.59M
Volume
228.96K
52W Range
$3.39 - $19.41
Target Price
$33.67
Key Metrics Overview
| Market Cap | $155.59M | P/E Ratio | N/A |
| 52W High | $19.41 | 52W Low | $3.39 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 91.8% | 52W Position | 83.2% |
| Overall Score | 52 | Value Score | 60 |
| Quality Score | 31 | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-5.8 | EPS Next Est | $-5.29 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $16.72 | -7.3% | 228.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |